227 related articles for article (PubMed ID: 15997385)
1. [Rheumatology].
Scherer HU; Burmester GR
Internist (Berl); 2005 Aug; 46(8):882-91. PubMed ID: 15997385
[TBL] [Abstract][Full Text] [Related]
2. Remittive agents in pediatric rheumatology.
Singer NG; Scalzi LV
Curr Opin Rheumatol; 2004 Sep; 16(5):571-6. PubMed ID: 15314497
[TBL] [Abstract][Full Text] [Related]
3. [Rheumatology, the multitude of options].
Morel J; Mulleman D
Med Sci (Paris); 2019 Dec; 35(12):1029-1033. PubMed ID: 31903914
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
Ferraccioli G; De Santis M; Tolusso B
Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in rheumatology in 2015: New tools to tackle inflammatory arthritis.
Dinarello CA; Joosten LA
Nat Rev Rheumatol; 2016 Feb; 12(2):78-80. PubMed ID: 26763730
[No Abstract] [Full Text] [Related]
6. [Therapeutic strategies in rheumatology. New concepts, new agents, observance of comorbidities].
Märker-Hermann E; Gross WL
Internist (Berl); 2011 Jun; 52(6):643-4. PubMed ID: 21584797
[No Abstract] [Full Text] [Related]
7. [Rheumatology: present and future].
Braun J
Dtsch Med Wochenschr; 2012 Sep; 137(36):1735. PubMed ID: 22933193
[No Abstract] [Full Text] [Related]
8. What is the future of targeted therapy in rheumatology: biologics or small molecules?
Mócsai A; Kovács L; Gergely P
BMC Med; 2014 Mar; 12():43. PubMed ID: 24620738
[TBL] [Abstract][Full Text] [Related]
9. Optimizing care for patients with rheumatic disease worldwide: a concept of global rheumatology.
Mittleman BB; Lipsky PE
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):575. PubMed ID: 17075591
[No Abstract] [Full Text] [Related]
10. Robin goodfellow.
Rheumatology (Oxford); 2002 Sep; 41(9):1081. PubMed ID: 12209049
[No Abstract] [Full Text] [Related]
11. Expanding possibilities in the treatment of patient groups with previously difficult-to-treat patients.
Dörner T; Burmester GR
Curr Opin Rheumatol; 2010 May; 22(3):235-6. PubMed ID: 20351494
[No Abstract] [Full Text] [Related]
12. Career lifetime advances in rheumatology.
Scott DL
Clin Med (Lond); 2010 Apr; 10(2):156-9. PubMed ID: 20437989
[No Abstract] [Full Text] [Related]
13. Biologic treatments for systemic rheumatic diseases.
Shirota Y; Illei GG; Nikolov NP
Oral Dis; 2008 Apr; 14(3):206-16. PubMed ID: 18282173
[TBL] [Abstract][Full Text] [Related]
14. [Intra-articular infiltrations in rheumatology: update].
Chevalier-Ruggeri P; Zufferey P
Rev Med Suisse; 2016 Jan; 12(500):90-4. PubMed ID: 26946713
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics in pediatric rheumatology.
Becker ML
Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
[TBL] [Abstract][Full Text] [Related]
16. New age of biological therapies in paediatric rheumatology.
Sen ES; Ramanan AV
Arch Dis Child; 2014 Jul; 99(7):679-85. PubMed ID: 24621445
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Förger F
Ther Umsch; 2016; 73(7):385-391. PubMed ID: 27998251
[No Abstract] [Full Text] [Related]
18. Biologic therapies in rheumatology: lessons learned, future directions.
Strand V; Kimberly R; Isaacs JD
Nat Rev Drug Discov; 2007 Jan; 6(1):75-92. PubMed ID: 17195034
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases.
Ciechomska M; O'Reilly S
Mediators Inflamm; 2016; 2016():9607946. PubMed ID: 27594771
[TBL] [Abstract][Full Text] [Related]
20. [Treat-to-target in rheumatology].
Majdan M
Wiad Lek; 2015; 68(3):259-64. PubMed ID: 26753210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]